OKAI Stock Overview
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
EvokAI Creative Labs Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.13 |
| 52 Week High | CA$2.15 |
| 52 Week Low | CA$0.075 |
| Beta | 0 |
| 1 Month Change | 30.00% |
| 3 Month Change | 0% |
| 1 Year Change | -88.70% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -90.00% |
Recent News & Updates
Recent updates
Shareholder Returns
| OKAI | CA Healthcare Services | CA Market | |
|---|---|---|---|
| 7D | 0% | 2.4% | -0.6% |
| 1Y | -88.7% | 18.3% | 3.9% |
Return vs Industry: OKAI underperformed the Canadian Healthcare Services industry which returned 18.3% over the past year.
Return vs Market: OKAI underperformed the Canadian Market which returned 3.9% over the past year.
Price Volatility
| OKAI volatility | |
|---|---|
| OKAI Average Weekly Movement | n/a |
| Healthcare Services Industry Average Movement | 13.5% |
| Market Average Movement | 9.1% |
| 10% most volatile stocks in CA Market | 18.3% |
| 10% least volatile stocks in CA Market | 3.1% |
Stable Share Price: OKAI has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine OKAI's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| n/a | n/a | Alejandro Antalich | www.evokailabs.com |
EvokAI Creative Labs Inc., a MedTech artificial-intelligence (AI)-powered company, engages in the development of transformational technologies for the healthcare sector. The company’s artificial intelligence-enhanced diagnostic profiles provide a basis to monitor mental wellbeing and enable advances in medical diagnoses. It deploys machine learning models to search medical data, integrate novel medical devices, and uncover insights to help improve health outcomes, patient experiences, drug development, preclinical and clinical decisions, and provide accurate diagnoses.
EvokAI Creative Labs Inc. Fundamentals Summary
| OKAI fundamental statistics | |
|---|---|
| Market cap | CA$9.89m |
| Earnings (TTM) | -CA$6.71m |
| Revenue (TTM) | CA$17.49k |
565.2x
P/S Ratio-1.5x
P/E RatioIs OKAI overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| OKAI income statement (TTM) | |
|---|---|
| Revenue | US$12.77k |
| Cost of Revenue | US$0 |
| Gross Profit | US$12.77k |
| Other Expenses | US$4.91m |
| Earnings | -US$4.90m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.064 |
| Gross Margin | 100.00% |
| Net Profit Margin | -38,375.78% |
| Debt/Equity Ratio | 6.6% |
How did OKAI perform over the long term?
See historical performance and comparison